-
KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Plus Paclitaxel ± Bevacizumab, Approved for Certain Adults with PD-L1+ (CPS ≥1) Platinum-Resistant Ovarian Carcinoma as Second or Third Line Treatment
11 Feb 2026 17:30 GMT
… outside of controlled trials. Immune-mediated adverse … and CAPOX (capecitabine plus oxaliplatin) or FP (5 … to clinical trial participation, screening and treatment, we work … ONCOLOGY RETAIL HEALTH FDA HOME GOODS PHARMACEUTICAL BIOTECHNOLOGY
SOURCE: Merck …
-
Stage 4 stomach cancer patients face treatment gaps as Vyloy reimbursement stalls
10 Feb 2026 13:27 GMT
… .2 targeted anticancer drug Vyloy (zolbetuximab), … Vyloy and mFOLFOX6 (oxaliplatin, leucovorin, fluorouracil) … negotiations with the Pharmaceutical Reimbursement Evaluation Committee (PREC … therapy abandon treatment due to cost issues,” a medical oncologist …
-
The Landscape of Ferritin Nanocages for Neurodegenerative Diseases Treatment
05 Feb 2026 13:53 GMT
… diseases, current clinical treatment options remain extremely limited … include ethanol and certain antidepressants.45,56
Adsorption- … in nose-to-brain drug delivery. Pharmaceutics. 2021;13:201 … et al. Glioma-targeted oxaliplatin/ferritin clathrate reversing …
-
Developments & Potential of Nanotechnology for the Detection and Treatment of Pancreatic Cancer
04 Feb 2026 23:47 GMT
… oxaliplatin (NALIRIFOX).52 The NAPOLI 3 trial … trials involving other common chemotherapy drugs.
Table 1 Clinical Trials Involving Nanoparticles for the Treatment … applications. Pharmaceutics. 2022;14(2):435 … Biophotonics and biotechnology in pancreatic cancer: …
-
<![CDATA[FDA to Review New Drug Combo for Previously Treated Metastatic Colorectal Cancer]]>
02 Feb 2026 19:52 GMT
… and Drug Administration (FDA) has accepted a new drug application … already received fluoropyrimidine-, oxaliplatin- and irinotecan-based … European Society for Medical Oncology Congress and … discuss emerging treatment options and trial opportunities with …
-
Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint Inhibitor for Patients with Metastatic Colorectal Cancer
02 Feb 2026 16:35 GMT
… with fluoropyrimidine-, oxaliplatin- and irinotecan-based … in a challenging treatment landscape, and … medicines and regimens at the forefront of cancer care. Powered by drug … KEYWORD: ONCOLOGY FDA HEALTH CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY
SOURCE: …
-
The Prospects of Palmitylethanolamide in Tumor Prevention and Treatment
30 Jan 2026 23:54 GMT
… Therapy and Translational Medicine
Molecular precision therapy … cancer patients treated with oxaliplatin. This observational study … inflammatory approach to sarcopenia. Pharmaceutics. 2022;14(3):648 … . Davis P. Novel drug treatments for pain in advanced …
-
Research Progress on Nano-Drug Delivery Systems for Photothermal Cancer Therapy
29 Jan 2026 21:00 GMT
… checkpoint blockers (ICB) and oxaliplatin (OXA));50 and ③ … dependence on specialized medical infrastructure.57
These … Nanotechnology-based drug delivery for breast cancer treatment: current … therapies using nanoplatforms. Pharmaceutics. 2025;17(3):306 …
-
From Teriparatide to Pembrolizumab: CDSCO Clears Import of r-DNA Drugs via CT-18 Route
26 Jan 2026 13:24 GMT
… the New Drugs and Clinical Trials Rules and … Intas Pharmaceuticals Ltd’s Serplulimab, Sun Pharmaceutical Industries Ltd … combination with a statin or statin with other lipid … progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan …
-
<![CDATA[FDA Approves Liquid Biopsy CDx for Encorafenib Regimen in BRAF V600E+ CRC]]>
22 Jan 2026 22:03 GMT
… metastatic colorectal cancer, supported the FDA’s decisions. Notably, BREAKWATER … oxaliplatin, leucovorin, and 5-fluouracil (mFOLFOX6).3
Eligible patients in the trial … had not received prior systemic treatment for metastatic disease. Additional enrollment …
About
© 1995-2026